Malaria. Tuberculosis. Alzheimer's disease. AIDS. Pandemic flu. Genital herpes. Urinary tract infections. Grass allergies. Traveler's diarrhea. You name it, the pharmaceutical industry is working on a vaccine to prevent it.
A day after Poniard Pharmaceuticals Inc. said its drug candidate picoplatin failed to improve survival for patients with lung cancer, the company reported positive data on the drug as a treatment for colorectal cancer.
Federal health officials said a popular variety of heartburn medications can interfere with the blood thinner Plavix, a drug taken by millions of Americans to reduce risks of heart attack and stroke.
A glowing, eerily beautiful image of a water flea with its radiant green “crown of thorns” took top prize in the 2009 Olympus BioScapes Digital Imaging Competition, a forum for showcasing microscope photos and movies of life science subjects.
Life Technologies Corporation has signed a definitive agreement to acquire BioTrove, Inc. for an undisclosed amount.
A technical poster from Fluidigm Europe that demonstrates a new approach, which when used in combination with Fluidigm's BioMark real-time PCR system, provides a simple, inexpensive and reproducible solution to single cell gene expression.
Orion Genomics has entered into a multi-year collaboration and license agreement with the molecular diagnostics unit of Novartis Pharma AG.
DASGIP AG premiered its Remote Control Suite at the Biotechnica. Scientists can use an iPhone, iPod touch, or notebook computer to remotely observe and access running processes.
FACSmax from amsbio is proven highly effective in creating single cell suspensions from clumped cell cultures enabling accurate, reproducible cell counting, flow cytometry, viral transfection assays, cell sorting, and bioreactor scale-up.
Researchers at Queen's University have found a link between two genes involved in cancer formation in humans, by examining the genes in worms.
Age-related hearing loss is the most common sensory disorder among the elderly. But scientists are still trying to figure out what cellular processes govern or contribute to the loss.
Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research at NewYork-Presbyterian Hospital/Columbia University Medical Center.
Utah Attorney General Mark Shurtleff says the state has agreed to a $24 million civil settlement with Eli Lilly & Co. over claims the drug maker engaged in off-label marketing of the anti-psychotic drug Zyprexa.
As federal regulators take their first tentative steps toward policing the wild west of medical information online, pharmaceutical companies are pressing their case to market drugs via Google, Twitter and other Web sites.
Cumberland Pharmaceuticals Inc. said its profit rose 6 percent in the third quarter, as sales of its recently approved fever and pain treatment Caldolor were partly offset by costs to launch the drug.